Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Development of composition and technology of the new anti-ischemic drug product

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: TESLEV, Andrey (Saint Petersburg State Chemical-Pharmaceutical Academy, Center of Pharmaceutical Technology, Saint Petersburg, Russian Federation)
  • Co-author(s): Andrey Teslev: Center of Pharmaceutical Technology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation
    Dmitriy Ivkin: Center of Experimental Pharmacology, Saint Petersburg State Chemical-Pharmaceutical Academy, Saint Petersburg, Russian Federation
  • Abstract:

    Backgrounds

    Ischemic heart disease and its acute forms - myocardial infarction and unstable angina - are widespread nowadays and are characterised by a high risk of death.

    Aims

    Development of formulation, technological approaches and quality control techniques for film-coated tablets of 4-(3-ethoxy-3-oxopropanamido)benzoic acid

    Methods

    Physical,

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses